Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference

Core Viewpoint - Revelation Biosciences, Inc. will participate in the 38th Annual Roth Conference, highlighting its focus on rebalancing inflammation to optimize health [1][3]. Group 1: Company Overview - Revelation Biosciences, Inc. is a clinical-stage life sciences company that utilizes its proprietary formulation, Gemini, to address various health issues [3]. - The company is currently evaluating Gemini for multiple applications, including treatment for acute kidney injury, chronic kidney disease, prevention of post-surgical infection, and reduction of hyperinflammation and infection associated with severe burns [3]. Group 2: Conference Participation - James Rolke, the CEO, and Chester S. Zygmont, III, the CFO, will attend the Roth Conference on March 23rd and 24th, 2026, with a fireside chat scheduled for March 24 at 2:00 p.m. PT [1]. - The fireside chat will be available via live webcast and can be accessed later on the company's investor relations section of its website [2].